Structural Heart

View the latest content related to this topic

News Daily News

CMS Agrees to Reimburse Tricuspid TEER

The overall evidence for the procedure is “insufficient” at present, but good enough to allow coverage, the agency says.

Todd Neale

July 07, 2025

Slides

See all

Presentation EuroPCR 2025

Surgical versus percutaneous treatment of bicuspid aortic stenosis: a propensity score analysis

Presenter: Pierre Deharo

May 22, 2025

Presentation EuroPCR 2025

One-year outcomes of LANDMARK

Presenter: Patrick W. Serruys

May 22, 2025

Presentation EuroPCR 2025

Angiography versus physiology-guided PCI in patients undergoing TAVI: the functional assessment in TAVI (FAITAVI) trial

Presenter: Flavio Ribichini

May 22, 2025

Presentation ACC 2025

Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial

Presenter: Saibal Kar

March 30, 2025

Presentation ACC 2025

Dapagliflozin after Transcatheter Aortic Valve Implantation

Presenter: Sergio Raposeiras-Roubin

March 29, 2025

News

See all

News Daily News

People With Tricuspid Valve Disease Want More Information, Sooner

By Yael L. Maxwell

July 17, 2025

News Daily News

Carbon Footprint of Surgical AVR Double the Size of TAVI’s

By Yael L. Maxwell

July 15, 2025

News Daily News

CMS Agrees to Reimburse Tricuspid TEER

By Todd Neale

July 07, 2025

News Conference News NY Valves 2025

No Benefit of Sentinel Device During TAVI: Updated Meta-analysis

By Todd Neale

July 04, 2025

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

By Yael L. Maxwell

July 03, 2025

ACC 2025

March 29

March 31, 2025

CTO 2025

February 28

March 01, 2025

THT 2025

February 11

February 13, 2025

Videos on This Topic

See all

Advertisement

Structural Heart

CMS Agrees to Reimburse Tricuspid TEER

Slides

Surgical versus percutaneous treatment of bicuspid aortic stenosis: a propensity score analysis

One-year outcomes of LANDMARK

Angiography versus physiology-guided PCI in patients undergoing TAVI: the functional assessment in TAVI (FAITAVI) trial

Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial

Dapagliflozin after Transcatheter Aortic Valve Implantation

News

People With Tricuspid Valve Disease Want More Information, Sooner

Carbon Footprint of Surgical AVR Double the Size of TAVI’s

CMS Agrees to Reimburse Tricuspid TEER

No Benefit of Sentinel Device During TAVI: Updated Meta-analysis

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

More on This Topic

Conference Coverage

ACC 2025

CTO 2025

THT 2025

Videos on This Topic

Advertisement

Structural Heart

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content